Sign Up
HR 2623 United States House · 117th Congress

Cameron’s Law

Summary
Cameron's Law This bill increases the rate of the tax credit for clinical testing expenses for rare diseases or conditions from 25% to 50% (orphan drug tax credit). The bill also requires the Centers for Disease Control and Prevention to complete a study to evaluate the feasibility of enhancing and expanding the infrastructure to track the epidemiology of rare diseases or conditions.
Issues: ✓ Budget & TaxesSupports Budget & TaxesIncreases orphan drug tax credit rate from 25% to 50%, providing direct tax relief for clinical testing expenses related to rare diseases.95% confidence ✓ HealthcareSupports HealthcareIncreases tax credit for rare disease testing (50% rate) and mandates CDC study on rare disease tracking, enhancing patient access and public health infrastructure for rare conditions.95% confidence
Bill status in committee 1 of 4 stages cleared
Introduction
Apr 2021
Committee Review
Floor Vote
President
Introduced Apr 16, 2021 Last action Apr 19, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
2
Apr 19, 2021
Committee
Referred to the Subcommittee on Health.
lower
Apr 16, 2021
Committee
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
lower
Apr 16, 2021
Introduced
Introduced in House
lower
1 primary · 2 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Josh Gottheimer
Josh Gottheimer
DDemocratic
NJ
5
Co
Photo of Don Bacon
Don Bacon
RRepublican
NE
2
Co
Photo of Fred Upton
Fred Upton
RRepublican
MI
6